Urolithin A 8-Methyl Ether（35233-17-1）Specifications Product Name
Urolithin A 8-Methyl Ether powder
Chemical Name
3-hydroxy-8-methoxy-6H-benzo[c]chromen-6-one; 3-hydroxy-8-methoxybenzo[c]chromen-6-one; 35233-17-1; MLS001049096; SMR000386929; ChemDiv3_002724; Urolithin A 8-Methyl Ether;
CAS Number
35233-17-1
InChIKey
IGJLBTGXYKPECW-UHFFFAOYSA-N
Molecular Formula
C14H10O4
Molecular Weight
242.23
Monoisotopic Mass
242.057909 g/mol
Melting point
242 °C(Solv: acetic acid (64-19-7))
Boiling point
479.9±38.0 °C(Predicted)
Density
1.375±0.06 g/cm3(Predicted)
Biological Half-Life
N/A
Color
Light Beige to Very Dark Orange Solid
Solubility
Acetone (Slightly, Sonicated) DMSO (Slightly, Sonicated), Methanol (Slightly)
Storage Temperature
Hygroscopic,
-20°C
Freezer,
Under
inert
atmosphere Application
Urolithin A 8-Methyl Ether is an intermediate in the synthesis of Urolithin A (U847000), a major metabolite of Ellagitannin and exhibits anti-inflammatory and antioxidant properties.
What is Urolithin A 8-Methyl Ether? Urolithins are secondary metabolites of ellagic acid derived from ellagitannins. In humans ellagitannins are converted by the gut microflora into ellagic acid which is further transformed into urolithins A, urolithin B, urolithin C and urolithin D in the large intestines. Urolithin A 8-Methyl Ether is the intermediate product during the synthesis of Urolithin A. It is a significant secondary metabolite of ellagitannin and possess antioxidant and anti-inflammatory properties.
How does Urolithin A 8-Methyl Ether work? 1)Antioxidant properties Urolithin A 8-Methyl Ether has an antioxidant effect by reducing free radicals, especially reducing